| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3577840
Max Phase: Preclinical
Molecular Formula: C3H10O7P2
Molecular Weight: 220.05
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COP(=O)(O)C(C)(O)P(=O)(O)O
Standard InChI: InChI=1S/C3H10O7P2/c1-3(4,11(5,6)7)12(8,9)10-2/h4H,1-2H3,(H,8,9)(H2,5,6,7)
Standard InChI Key: YZPOVJAAHMUIMK-UHFFFAOYSA-N
Associated Targets(Human)
Hydroxyapatite 165 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 220.05 | Molecular Weight (Monoisotopic): 219.9902 | AlogP: -0.34 | #Rotatable Bonds: 3 |
| Polar Surface Area: 124.29 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 0.76 | CX Basic pKa: | CX LogP: -1.73 | CX LogD: -6.50 |
| Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.48 | Np Likeness Score: 0.50 |
References
| 1. Puljula E, Turhanen P, Vepsäläinen J, Monteil M, Lecouvey M, Weisell J.. (2015) Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters., 6 (4): [PMID:25893039] [10.1021/ml5004603] |
Source
Source(1):